Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Ncontact Surgical, Inc. — Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

89 daysmedian FDA review time
237 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K142084EPI-SENSE GUIDED COAGULATION DEVICE WITH VISITRAXNcontact Surgical, Inc.2014-10-28890
K120857EPI-SENSE GUIDED COAGULATION DEVICE WITH VISITRAXNcontact Surgical, Inc.2012-11-132370
K090202NUMERIS GUIDED COAGULATION SYSTEM WITH VISITRAX, MODELS CSK-Ncontact Surgical, Inc.2009-02-17210
K082203NUMERIS COAGULATION SYSTEM WITH VISITRAX, MODEL(S) CSK-021;CNcontact Surgical, Inc.2008-12-301470
K071819NCONTACT VISITRAX GUIDED COAGULATION SYSTEM KIT, MODELS CSK-Ncontact Surgical, Inc.2007-07-26230
K063012NCONTACT COAGULATION SYSTEM KIT, MODEL CSKNcontact Surgical, Inc.2006-12-01600
K062539NCONTACT COAGULATION SYSTEM KITNcontact Surgical, Inc.2006-12-01940

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda